In Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Author

We appreciate you signing up! You’re now part of our community and will be the first to receive our latest updates, exclusive offers, and special content. Stay tuned for exciting news and insights straight to your inbox.
Your name

Your email
By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Popular News
- In Investing
  Endeavour Silver Hits Updated 2024 Production Guidance After Disruption at Guanaceví Mine
  January 10, 2025 No Comments
- In Investing
  Zijin Mining in Talks to Acquire Stake in US$6.4 Billion Chinese Lithium Miner
  January 10, 2025 No Comments

Endeavour Silver Hits Updated 2024 Production Guidance After Disruption at Guanaceví Mine